Descripción del proyecto
Impresión 3D con corales marinos
La impresión 3D es una tecnología en rápido desarrollo que permite a los fabricantes del sector sanitario crear equipos y productos médicos personalizados. Zoan Biomed, una pyme pujante con sede en la costa oeste de Irlanda, está especializada en el cultivo de coral marino de calidad médica y en la creación de productos a partir de él que pueden utilizarse como sustitutos de los injertos óseos. Gracias al proyecto InnovationOrigin, financiado con fondos europeos, Zoan se propone crear un nuevo campo de aplicaciones potenciales a través del sector de la impresión 3D. Zoan está preparándose para entrar en el mercado mundial de la impresión 3D, valorado en 4 200 millones de dólares estadounidenses en 2014 y que se prevé que alcance un valor de 44 400 millones de dólares estadounidenses en 2025, registrando una tasa de crecimiento anual compuesto del 21,8 % entre 2019 y 2025.
Objetivo
Zoan BioMed is a dynamic SME based in the West coast of Ireland. Zoan has turned to nature, specifically the Ocean, for the blueprints to solve a major biomedical challenge. Zoan specialises in cultivating medical-grade marine coral and creating products from it that can be used as an Orthobiologic scaffold, for use as a bone graft substitute.
With the development of the InnovationOrigin Project, Zoan seeks to adapt and develop platform products as a material for use in 3D printers, to open up a new realm of potential applications for our products and in doing so create a significant market demand in new value chains. The development of 3D printing is now an exciting reality which provides enhanced career growth opportunities for each new generation of engineers and manufacturers entering the workforce. Furthermore, 3D printing technology is a rapid emerging technology which empowers manufacturers in the medical sector to produce customised medical equipment and products. If the project is successful, Zoan will be then in a position to enter the global 3D printing market which was valued at $4.2 billion in 2014, and is projected to reach $44.4 billion by 2025, registering a CAGR of 21.8% from 2019 to 2025.
The Innovation Associate will act as a catalyst, driving our innovation strategy in 3D printing forward and aligning with our business targets of growing capacity on site, building a vibrant hub of employment in a remote part of Connemara and bringing the biomimetic potential of our bio-material to a number of sectors.
Zoan will provide to the Innovation Associate with the opportunity to co-create their own future by helping to develop a new dimension to our business which they can champion and drive forward through defining new innovation projects and partnerships, making them an integral part of our team and providing them with a rewarding career in our company.
Ámbito científico
Palabras clave
Programa(s)
Convocatoria de propuestas
Consulte otros proyectos de esta convocatoriaConvocatoria de subcontratación
H2020-INNOSUP-2019-02
Régimen de financiación
CSA - Coordination and support actionCoordinador
H91 TXV5 Galway
Irlanda
Organización definida por ella misma como pequeña y mediana empresa (pyme) en el momento de la firma del acuerdo de subvención.